Pharmaceuticals News and Research

RSS

Mexican study shows mobility can be restored in patients with Parkinson's disease

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide.

22 Dec 2014

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

Myriad Genetics, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza™ (olaparib).

22 Dec 2014

Prostaglandin analogue eye drops reduce risk of vision loss in OAG patients

Prostaglandin analogue eye drops, the most commonly prescribed treatment for glaucoma, can greatly reduce risk of vision loss in people with open angle glaucoma (OAG), one of the leading causes of blindness, according to the first placebo-controlled trial to assess their vision-preserving effect published in The Lancet.

22 Dec 2014

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration approved the intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi). Erwinaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

19 Dec 2014

Oral budesonide suspension offers hope for pediatric patients with EoE

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

19 Dec 2014

Canopus BioPharma study confirms efficacy of CB008 drug for Ebola Virus inhibition

Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.

19 Dec 2014

Gene variations predispose mestizo Mexican population to develop severe form of COPD

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases, found that the mestizo Mexican population has a number of variations in certain genes that predispose them to develop the most severe form of chronic obstructive pulmonary disease (COPD).

19 Dec 2014

Sage Analytics releases new Luminary Profiler for testing cannabis potency

Sage Analytics, the developers of a new generation of equipment for the testing of marijuana potency and moisture content, announced today the release of the new Luminary Profiler, the industry's first product suite capable of delivering highly accurate light-based measurement in a cost-effective, portable unit.

18 Dec 2014

Mature motorists worse than younger counterparts when texting while driving

A Wayne State University interdisciplinary research team in the Eugene Applebaum College of Pharmacy and Health Sciences has made a surprising discovery: older, more mature motorists -- who typically are better drivers in many circumstances -- are much worse than their younger counterparts when texting while driving.

18 Dec 2014

$Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis$

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of immunology and topical products, today announced that 179 patients have completed its 16-week, double-blind, placebo-controlled, Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis.

18 Dec 2014

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the companies have entered into a strategic collaboration for the further clinical development and commercialization of CMX157.

18 Dec 2014

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

Inovio Pharmaceuticals, Inc. announced it has initiated a phase I trial of its hTERT DNA immunotherapy (INO-1400) alone or in combination with Inovio's IL-12 immune activator (INO-9012) in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments.

18 Dec 2014

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

Antimicrobial peptides are a distinctive class of potent, broad-spectrum antibiotics produced by the body's innate immune system--the first line of defense against disease-causing microbes.

18 Dec 2014

COUNTDOWN research consortium focuses on neglected tropical diseases

The COUNTDOWN research consortium has been launched today following a £7 million grant allocation from the UK Department for International Development earlier in the year.

18 Dec 2014

TSRI scientists discover new method for joining complex organic molecules

Chemists at The Scripps Research Institute have invented a powerful method for joining complex organic molecules that is extraordinarily robust and can be used to make pharmaceuticals, fabrics, dyes, plastics and other materials previously inaccessible to chemists.

18 Dec 2014

UK doctors to test cannabis-based medicine for children with severe epilepsy

Children with severe epilepsy could be helped by a new treatment derived from the cannabis plant.

18 Dec 2014

Antipsychotic polypharmacy prevalent despite efficacy doubts

Results of a retrospective study suggest that around a quarter of patients with schizophrenia receive antipsychotic polypharmacy, despite a lack of evidence for the approach.

17 Dec 2014

New training network project to develop medical statisticians to achieve drug development success

A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.

17 Dec 2014

Study provides new evidence for anti-cirrhotic effects of GENFIT's GFT505

GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces that a recent study provides new evidence for anti-cirrhotic effects of GFT505 in the context of NASH.

17 Dec 2014

Isis Pharmaceuticals begins ISIS-DMPK Rx clinical study in DM1 patients

Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.

16 Dec 2014

Pharmaceuticals News and Research

Mexican study shows mobility can be restored in patients with Parkinson's disease

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

Prostaglandin analogue eye drops reduce risk of vision loss in OAG patients

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

Oral budesonide suspension offers hope for pediatric patients with EoE

Canopus BioPharma study confirms efficacy of CB008 drug for Ebola Virus inhibition

Gene variations predispose mestizo Mexican population to develop severe form of COPD

Sage Analytics releases new Luminary Profiler for testing cannabis potency

Mature motorists worse than younger counterparts when texting while driving

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

COUNTDOWN research consortium focuses on neglected tropical diseases

TSRI scientists discover new method for joining complex organic molecules

UK doctors to test cannabis-based medicine for children with severe epilepsy

Antipsychotic polypharmacy prevalent despite efficacy doubts

New training network project to develop medical statisticians to achieve drug development success

Study provides new evidence for anti-cirrhotic effects of GENFIT's GFT505

Isis Pharmaceuticals begins ISIS-DMPK Rx clinical study in DM1 patients

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence